Series E - NGM Biopharmaceuticals - Mar 25, 2015 Funding Round Profile - Cointime

Bitcoin $87,951.21 +0.38%
Ethereum $3,253.39 -1.51%
BNB $618.38 -4.71%
Optimism $1.63 -10.01%
Arbitrum $0.62 -7.08%
Solana $207.53 -4.68%
Polygon $0.39 -6.78%
Cosmos $5.16 -7.57%
Avalanche $33.25 -6.08%

Bitcoin $87,951.21 +0.38%
Ethereum $3,253.39 -1.51%
BNB $618.38 -4.71%
Optimism $1.63 -10.01%
Arbitrum $0.62 -7.08%
Solana $207.53 -4.68%
Polygon $0.39 -6.78%
Cosmos $5.16 -7.57%
Avalanche $33.25 -6.08%

NGM Biopharmaceuticals

company

Funding Round

Series E

Money Raised

$ 105.99M

Propotion

-

Post Valuation

-

Current Round Investors

Investor Name	Invest Money	Lead Investor	Propotion
Merck	-	Yes	-	Detail